1887

Abstract

SUMMARY

Optimal conditions for the NBT-reduction test have been sought. Increasing heparin concentrations up to 100 units per ml and a delay in performance of the test, especially when blood specimens are kept at room temperature, resulted in higher values for the NBT index, which then sometimes exceeded the upper limit of normal in healthy people and in uninfected patients. The effect of H, composition of the buffer, and dye concentration was also investigated. Phosphate-buffered saline H 7.2 containing 0.1% NBT dye, without glucose, gave the most reliable results.

In endotoxin-stimulated NBT tests, the following procedure is recommended: incubation of 0.1 ml whole blood with lyophilised endotoxin 20 μg per ml, for 15 min. in a 37°C water bath, followed by the standard test with a 0.2% NBT solution. By this technique, the leucocyte reaction to various types of lipopolysaccharides was of the same order of magnitude. Drug therapy having an effect on blood components lowered this reaction, whatever the source of endotoxin used as stimulant.

The importance of NBT-reduction tests is discussed. Standard conditions of test performance are strictly requisite if comparable results are to be obtained and if data not corresponding with the apparent clinical and other laboratory findings are to be evaluated correctly. The stimulated NBT test, performed in parallel with the standard test, is useful in the interpretation of abnormal results and in the detection of factors with a temporary or permanent effect on the phagocytic activity of PMN leucocytes.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-8-2-375
1975-05-01
2022-01-25
Loading full text...

Full text loading...

/deliver/fulltext/jmm/8/2/medmicro-8-2-375.html?itemId=/content/journal/jmm/10.1099/00222615-8-2-375&mimeType=html&fmt=ahah

References

  1. Anner R. M., Nydegger U. E., Schmocker K., Lambert P. H., Miescher P. A. 1972; Etude experimental et clinique du test au NBT. Schweiz, med. Wschr 102:1606
    [Google Scholar]
  2. Baehner R. L. 1972; Conflicting results in metabolic studies of leukocytes from patients with osteogenesis imperfecta. Notes on NBT test. J. Pediat 80:346
    [Google Scholar]
  3. Baehner R. L., Nathan D. G. 1968; Quantitative nitroblue tetrazolium test in chronic granulomatous disease. New Eng. J. Med 278:971
    [Google Scholar]
  4. Bjorksten B., Solheim F. 1973; Oral contraceptives and the N.B.T. test. Lancet 1:830
    [Google Scholar]
  5. Charette R., Komp D. M. 1972; NBT test and incubation temperature. New Eng. J. Med 287:991
    [Google Scholar]
  6. Chretien J. H., Garagusi V. F. 1972; Corticosteroid effect on phagocytosis and NBT reduction by human polymorphonuclear neutrophils. J. reticuloendothel. Soc 11:358
    [Google Scholar]
  7. Farnes P., Povar M. L., Fieschko J., Barker B. E. 1972; N.B.T. tests in dog neutrophils. Lancet 1:47
    [Google Scholar]
  8. Feigin R. D. 1971; NBT test in the diagnosis of febrile patients. New Eng. J. Med 285:347
    [Google Scholar]
  9. Feigin R. D., Shackelford P. G., Choi S. C., Flake K. K., Francklin F. A. Jr, Eisenberg C. S. 1971; Nitroblue tetrazolium dye test as an aid in the differential diagnosis of febrile disorders. J. Pediat 78:230
    [Google Scholar]
  10. Freeman R., King B. 1972a; N.B.T. test. Lancet 2:380
    [Google Scholar]
  11. Freeman R., King B. 1972b; Technique for performance of the nitro-blue tetrazolium test. J. clin. Path 25:912
    [Google Scholar]
  12. Freeman R., King B., Kite P. 1973; Serial nitroblue tetrazolium tests in the management of infection. J. clin. Path 26:57
    [Google Scholar]
  13. Gifford R. H., Malawista S. E. 1972; The nitroblue tetrazolium reaction in human granulocytes adherent to a surface. Yale J. Biol. Med 45:119
    [Google Scholar]
  14. Gordon A. M., Rowan R. M., Brown F., Carson H. G. 1973; Routine application of the nitroblue tetrazolium test in the clinical laboratory. J. clin. Path 26:52
    [Google Scholar]
  15. Humbert J. R., Marks M. I., Hathaway W. E., Thoren C. H. 1971; The histo-chemical nitroblue tetrazolium reduction test in the differential diagnosis of acute infections. Pediatrics, Springfield 48:259
    [Google Scholar]
  16. Lancet (Leading Article) 1971 Nitroblue tetrazolium: a routine test? 2:909
  17. Mandell G. L., Fuller L. F. 1972; Nitroblue tetrazolium dye test: a diagnostic aid in tuberculosis. Amer. Rev. resp. Dis 105:123
    [Google Scholar]
  18. Matula G., Paterson P. Y. 1971a; Spontaneous in vitro reduction of nitroblue tetrazolium by neutrophils of adult patients with bacterial infection. New Eng. J. Med 285:311
    [Google Scholar]
  19. Matula G., Paterson P. Y. 1971b; N.B.T. tests in a patient on steroids. Lancet 1:803
    [Google Scholar]
  20. Matula G., Raas M. 1973; Nitroblue tetrazolium dye test. Ann. intern. Med 79:758
    [Google Scholar]
  21. Miescher P. A., Lambert P. H. 1972; L’apport du test au NBT dans le diagnostic des etats inflammatoires. Praxis 61:335
    [Google Scholar]
  22. Nydegger U. E., Miescher A., Anner R. M., Creighton D. W., Lambert P. H., Miescher P. A. 1973; Serum and cellular factor involvement in nitroblue tetrazolium (NBT) reduction by human neutrophils. Klin. Wschr 51:377
    [Google Scholar]
  23. Park B. H. 1971; The use and limitations of the nitroblue tetrazolium test as a diagnostic aid. /. Pediat 78:376
    [Google Scholar]
  24. Park B. H., Fikrig S. M., Smithwick E. M. 1968; Infection and nitroblue tetrazolium reduction by neutrophils. A diagnostic aid. Lancet 2:532
    [Google Scholar]
  25. Park B. H., Good R. A. 1970; N.B.T. test stimulated. Lancet 2:616
    [Google Scholar]
  26. Pujol-Moix M. N. 1973; Nitroblue-tetrazolium reducing capacity of neutrophils in diabetes. New Eng. J. Med 289:920
    [Google Scholar]
  27. Rubinstein A., Pelet B. 1973; False-negative N.B.T. tests due to a transient malfunction of neutrophils. Lancet 1:382
    [Google Scholar]
  28. Segal A. W., Levi A. J. 1973; The mechanism of the NBT (nitroblue tetrazolium) test. Clin. Sci 44:26P
    [Google Scholar]
  29. Sobel J. D., Obedeanu N., Blank S., Levy I., Valero A., Merzbach D. 1973; The nitroblue tetrazolium test in the investigation of febrile patients. S. Afr. med. J 47:1407
    [Google Scholar]
  30. Štrukelj M., Žemva M. 1973; Modification of the N.B.T. test. Lancet 1:149
    [Google Scholar]
  31. Tadmor B., Altmann G. 1971; The NBT test in patients with various infections. Harefuah 83:155
    [Google Scholar]
  32. Tan C. V., Rosner F., Feldman F. 1973; Nitroblue tetrazolium dye reduction in various hematologic disorders. N. Y. State J. Med 73:952
    [Google Scholar]
  33. Vaucher A., Wyss M., Th£voz F., Knopfel M., Miescher P. A. 1970; La reduction du nitrobleu de tetrazolium par les granulocytes dans divers etats cliniques. Schweiz, med. Wschr 100:2248
    [Google Scholar]
  34. Vega G. de la, Freyre-Horta R., Benitez-Bibriesca L. 1973; Plasma factor affecting the NBT reducing capacity of neutrophils. New Eng. J. Med 289:271
    [Google Scholar]
  35. Wenger M. E., Bole G. G. 1973; Nitroblue tetrazolium dye reduction by peripheral leukocytes from rheumatoid arthritis and systemic lupus erythematosus patients measured by a histochemical and spectrophotometric method. J. Lab. clin. Med 82:513
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-8-2-375
Loading
/content/journal/jmm/10.1099/00222615-8-2-375
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error